Merck & Company (DE:6MK)

XETRA:6MK

6MK

Merck & Company

RESEARCH TOOLSreports

Want to see DE:6MK full AI Analyst Report?

Compare Merck & Company (6MK) vs. Competitors

69 Followers

Comparison Results

6MK

Merck & Company

€99.28

€233.85B

-17.53

37.71%

13 Buy

7 Hold

0 Sell

Moderate Buy

Gilead Sciences

$137.64

$163.06B

21.41

33.79%

18 Buy

5 Hold

0 Sell

Strong Buy

Novartis

$151.97

$265.82B

23.10

32.60%

3 Buy

3 Hold

0 Sell

Moderate Buy

Pfizer

$27.56

$146.36B

14.70

11.80%

8 Buy

12 Hold

2 Sell

Moderate Buy

Sanofi

$48.06

$103.53B

15.55

-16.92%

0 Buy

3 Hold

0 Sell

Hold

AstraZeneca

15118.00 p

£206.95B

24.41

31.68%

13 Buy

1 Hold

1 Sell

Strong Buy

xxxxxxxxxxxxx

6MK vs AZN

xxxxxxxxxxxxx

Performance Comparison

DE:6MK

Merck & Company

95.16

26.15

37.89%

GILD

Gilead Sciences

131.33

30.20

29.86%

NVS

Novartis

146.03

39.17

36.66%

PFE

Pfizer

25.68

4.10

18.99%

SNY

Sanofi

43.31

-5.79

-11.80%

GB:AZN

AstraZeneca

13,344.00

3,247.96

32.17%

Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts

Compare More Stocks >